Durable Response to Chemoimmunotherapy in a Patient with RefractoryMetastatic Ovarian Clear Cell Carcinoma: A Case Report and Literature Review [0.03%]
Lili Wang,Xinyang Chen,Yuanyuan Li et al.
Lili Wang et al.
Objective: Ovarian clear cell carcinoma (OCCC) frequently exhibits resistance to conventional chemotherapy with limited treatment options. This study reports a heavily pretreated advanced case with liver metastases to inv...
Chenxin Zhou,Haixia Yang,Shilin Liu et al.
Chenxin Zhou et al.
Background: Langerhans cell histiocytosis (LCH) is a rare inflammatory neoplasm most commonly involving bone. However, data on single-system, single-site LCH (SS-s-LCH), particularly with unifocal bone disease, remain lim...
Proactive Identification of Candidates for Newly-Approved Targeted Therapies Using a Clinical Decision Support Program [0.03%]
Rebecca Feldman,Farah Abdulla,Andrew Hinton et al.
Rebecca Feldman et al.
Background: Comprehensive molecular profiling (CMP) enables identification of multiple biomarkers from a single sample to inform targeted therapy selection. However, the static nature of test reports limits their clinical...
Exploring biologically-based complementary and alternative medicine use among Irish cancer survivors: findings from a national survey [0.03%]
Clodagh Scannell,Erin Stella Sullivan,Karen Matvienko-Sikar et al.
Clodagh Scannell et al.
Background: Biologically based complementary and alternative medicine (BBCAM) includes special diets, dietary supplement and herbal remedies, not prescribed by a doctor or dietitian. The use of BBCAM is common among cance...
Effect of Patient Factors and Quality of Life on ECOG Assignment and Inter-Rater Agreement in Hospitalized Cancer Patients [0.03%]
Noel Blaya Boluda,Esmeralda García-Torralba,Alberto García-Romero et al.
Noel Blaya Boluda et al.
Background: Assigning the ECOG performance status is critical for decision-making in oncology, but it poses challenges in hospitalized patients due to lower concordance and potential alteration by factors related to admis...
Jennifer Segar,Kiah Farr,Mary Junak et al.
Jennifer Segar et al.
Background: Bone metastases (BM) from breast cancer cause significant cancer-induced bone pain (CIBP). Management of CIBP is primarily with opioids, which have notable side effects. In preclinical models, cannabinoid rece...
Multicenter phase II study of Neoadjuvant FOLFOXIRI Followed by Concurrent Chemoradiotherapy in Chinese Patients with High-Risk Rectal Cancer [0.03%]
Rashid N Lui,Simon Chu,Dennis Ck Ng et al.
Rashid N Lui et al.
Background: We investigated the feasibility of adding neoadjuvant FOLFOXIRI to chemoradiotherapy (CRT) in Chinese patients with high-risk, locally advanced rectal adenocarcinoma (LARC) and examined the prognostic signific...
BCMA-Targeted Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: Three Approvals, Many Questions [0.03%]
Samer Al Hadidi,Adeel M Khan,Aimaz Afrough et al.
Samer Al Hadidi et al.
Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinoma [0.03%]
Nobuyuki Takahashi,Chikako Funasaka,Mai Shimura et al.
Nobuyuki Takahashi et al.
Background: The KEYNOTE-522 (KN522) trial demonstrated significantly improved outcomes with neoadjuvant chemotherapy (NAC) combined with pembrolizumab in high-risk triple-negative breast cancer (TNBC). However, the effica...
Real-world feasibility and effectiveness of a personalized exercise program during cancer treatment: results from the CHOiCE prospective study [0.03%]
基于选择的癌症治疗期间个性化运动方案的真实性和有效性：CHOiCE前瞻性研究结果
Alice Avancini,Anita Borsati,Gloria Adamoli et al.
Alice Avancini et al.
Background: Despite strong evidence supporting exercise in oncology, real-world data on its feasibility and effectiveness across cancer types remain limited. The CHOiCE (Choose Health: Oncological patients Centered Exerci...